MML Investors Services’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Buy
17,461
+2,190
+14% +$50.7K ﹤0.01% 2545
2026
Q1
$314K Sell
15,271
-13,774
-47% -$310K ﹤0.01% 2528
2025
Q4
$689K Buy
29,045
+11,777
+68% +$287K ﹤0.01% 2040
2025
Q3
$430K Sell
17,268
-3,638
-17% -$78.3K ﹤0.01% 2274
2025
Q2
$481K Sell
20,906
-176
-0.8% -$4.08K ﹤0.01% 2123
2025
Q1
$473K Buy
21,082
+997
+5% +$23.2K ﹤0.01% 2015
2024
Q4
$393K Buy
20,085
+1,449
+8% +$28.7K ﹤0.01% 2088
2024
Q3
$339K Sell
18,636
-1,007
-5% -$19.2K ﹤0.01% 2095
2024
Q2
$341K Sell
19,643
-1,629
-8% -$28.9K ﹤0.01% 2012
2024
Q1
$417K Buy
21,272
+2,898
+16% +$61.2K ﹤0.01% 1905
2023
Q4
$423K Buy
18,374
+6,262
+52% +$140K ﹤0.01% 1845
2023
Q3
$279K Sell
12,112
-109
-0.9% -$2.77K ﹤0.01% 1973
2023
Q2
$319K Buy
+12,221
New +$323K ﹤0.01% 1907

Other funds holding PRVA

MML Investors Services's PRVA Position: Q2 2026 in Review

MML Investors Services increased its Privia Health (PRVA) stake by 14% in Q2 2026, buying an estimated $50.7K and bringing the position to 17,461 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

MML Investors Services first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. The position peaked at $689K in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • MML Investors Services held 17,461 shares of Privia Health worth $449K as of Q2 2026.
  • MML Investors Services bought 2,190 Privia Health shares in Q2 2026, an estimated $50.7K.
  • Privia Health made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2545 holding.
  • MML Investors Services first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • MML Investors Services's Privia Health position peaked at $689K in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.